Chidamide, a novel inhibitor of histone deacetylases, can suppress the Class 1 HDACs HDAC1, HDAC2, HDAC3, and HDAC8 in DLBCL cell lines16. This evidence concerns the gene HDAC8 and diffuse large B-cell lymphoma.